A preclinical study demonstrates that genetically modified outer membrane vesicles delivering poly-neoepitopes can treat colorectal cancer and lung metastasis in mice, highlighting the potential of novel delivery vectors for neoantigen vaccines.PubMed
Nothing published in the last 14 days cleared the bar. Below is the most relevant background we're tracking.
Relevant work from earlier we're still surfacing — not today's news.